Boothbay Fund Management, LLC Enanta Pharmaceuticals Inc Transaction History

Boothbay Fund Management, LLC

  • $3.27 Billion
  • Q4 2024

A detailed history of Boothbay Fund Management, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 85,649 shares of ENTA stock, worth $608,107. This represents 0.02% of its overall portfolio holdings.

Number of Shares
85,649
Previous 149,425 42.68%
Holding current value
$608,107
Previous $1.55 Million 68.24%
% of portfolio
0.02%
Previous 0.04%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$5.75 - $12.99 $366,712 - $828,450
-63,776 Reduced 42.68%
85,649 $492,000
Q3 2024

Nov 14, 2024
SELL
$10.05 - $16.54 $3.36 Million - $5.52 Million
-333,851 Reduced 69.08%
149,425 $1.55 Million
Q2 2024

Aug 14, 2024
BUY
$11.43 - $17.02 $1.08 Million - $1.61 Million
94,676 Added 24.36%
483,276 $6.27 Million
Q1 2024

May 15, 2024
BUY
$10.08 - $17.46 $3.92 Million - $6.78 Million
388,600 New
388,600 $6.78 Million
Q3 2020

Nov 16, 2020
SELL
$43.36 - $53.53 $867,200 - $1.07 Million
-20,000 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$46.37 - $57.58 $185,480 - $230,320
-4,000 Reduced 16.67%
20,000 $1 Million
Q1 2020

May 15, 2020
SELL
$40.22 - $62.0 $160,880 - $248,000
-4,000 Reduced 14.29%
24,000 $1.23 Million
Q3 2019

Nov 14, 2019
BUY
$60.08 - $88.17 $720,960 - $1.06 Million
12,000 Added 75.0%
28,000 $1.68 Million
Q2 2019

Aug 14, 2019
BUY
$81.3 - $97.35 $1.3 Million - $1.56 Million
16,000 New
16,000 $1.35 Million

Others Institutions Holding ENTA

# of Institutions
108
Shares Held
19.7M
Call Options Held
9.7K
Put Options Held
12.4K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $147M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email